The EPS projection of Globus Medical, Inc. (NYSE:GMED) for quarter ended 2016-09-30 is $0.3. Last week, the projection for EPS was $0.3 against target of $0.3, a month earlier. While 2-months ago, this projection was $0.3 versus forecast of $0.3a quarter months earlier, posting a deviation of 0%.
Globus Medical, Inc. (NYSE:GMED) posted that 18 days earlier, the share price was revised 1 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for Globus Medical, Inc. (NYSE:GMED) in the preceding 30 and 120 were 1 and 1. While in 60 and 90 days were 1, and 1, in that order.
Globus Medical, Inc. (NYSE:GMED) EPS target was $0.3 for the quarter closed 1. It was based on 7 calls. As on 2016-05-03 the EPS was $0.29. The change was $0.01, posting a deviation of 3.57%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
Globus Medical, Inc. (NYSE:GMED) sales prediction for the fiscal 2016 stands at $155.233 and the median estimate is at $155.2. Almost 3 analysts gave sales target.
Among this, the highest sales estimate is $156.3 while the lowest target is $154.2 showing standard deviation of 1.05%.
As many as 3 analysts have positive sales targets revision while 3 reduced sales estimates, posting a deviation of 0%.
Last month, 3 experts have positive sales number revision. Also, 3 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast, posting a deviation of 0.441%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...